Alcon® Dry Eye & Ocular Health Resource Center
Underlining the importance of healthy tears for overall eye health and vision, Alcon, the global leader in Eye Care, is on a mission to increase the awareness of Dry Eye & Ocular Health. Here you will find best practices in the treatment of ocular surface diseases, access to latest clinical research and studies in the field of Ophthalmology.
NEWS & UPDATES
Our goal is to help people see brilliantly, and to support eye care practitioners with the latest information & research.
Here you will find a curated and ever expanding library of resources exploring Dry Eye in terms of its fundamentals, Peri-operative Dry Eye, Iatrogenic and Secondary Dry Eye.
EVENTS & WEBINARS
Training and education can take many forms, appealing to different learning styles and preferences. Webinars are one of those formats, allowing for on-demand access to sessions prepared and delivered by leading names in that area.
EDUCATION & SCIENTIFIC SUPPORT
The OCU-LINK™ Educational resource library on Alcon Experience Academy™ is a curated, and ever expanding collection, of useful and informative assets. Assets that have been developed by Key Opinion Leaders, Academics and other experts in their field. Split into four sections you will be able to find information on:
⦿ Dry Eye Fundamentals
⦿ Peri-operative Dry Eye
⦿ Iatrogenic and Secondary Dry Eye, and
⦿ The Systane® Portfolio
MEET THE SYSTANE® FAMILY!
Learn more about Systane®, the #1 Global Consumer brand of Artificial Tears1. Find the Systane® product that is right for your patients, depending on their symptoms and underlying causes.
Also, learn more about Systane® proprietary HP-Guar® intelligent delivery system. Hydroxypropyl-guar or HP-Guar® acts as a gelling agent, creating an elastic matrix on the corneal surface upon installation2.
References:
1. Systane - MIDAS Audit, Dollars, MAT 06/2021 - IQVIA Consumer Health Insights.
2. MarketScope LLC. 2019 Dry Eye Products Report: A Global Market Analysis for 2018 to 2024. St. Louis, MO: MarketScope LLC; 2019.
3. Craig JP, Nelson JD, Azar DT, et al. TFOS DEWS II Report Executive Summary. Ocular Surface. 15(2017):802-812.
See instructions for use, precautions, warnings and contraindications
